Lataa...
Integrated analysis of patient samples identifies biomarkers for venetoclax efficacy and combination strategies in acute myeloid leukemia
Deregulation of the BCL2 gene family plays an important role in the pathogenesis of acute myeloid leukemia (AML). The BCL2 inhibitor, venetoclax, has received FDA approval for the treatment of AML. However, upfront and acquired drug resistance ensues due, in part, to the clinical and genetic heterog...
Tallennettuna:
| Julkaisussa: | Nat Cancer |
|---|---|
| Päätekijät: | , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7591155/ https://ncbi.nlm.nih.gov/pubmed/33123685 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s43018-020-0103-x |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|